Prestige Consumer Healthcare Inc. — Fiscal 2027 Second Quarter Earnings Summary

Prestige Consumer Healthcare Inc. reported fiscal 2027 second-quarter revenue of $336.3 million, a 22.7% increase year-over-year, driven by contributions from the Breathe Right and LaCorium acquisitions. Adjusted diluted earnings per share for the quarter reached $1.13, while the company updated its full-year fiscal 2027 revenue guidance to a range of $1,280 million to $1,290 million. The revised outlook reflects production variability at the Pillar5 facility affecting Clear Eyes availability, though the company maintains confidence in its long-term growth strategy and free cash flow generation.